The Romark Institute for Medical Research;
Tampa;
Florida and Sausalito;
California;
United States and the Division of Gastroenterology and Hepatology;
Department of Medicine;
Stanford University Medical Center;
The Romark Institute for Medical Research;
Tampa;
Florida;
United States and the Division of Gastroenterology and Hepatology;
Department of Medicine;
Stanford University Medical Center;
慢性病毒性肝炎; 第二代; 治疗; th; 聚乙二醇化干扰素; 慢性乙型肝炎患者; 持续病毒学应答率; 乙型肝炎表面抗原;